BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei L, Chen C, Ding L, Mo M, Zou J, Lu Z, Li H, Wu H, Dai Y, Xu P, Lu Z. Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease. Neural Plast 2019;2019:1247276. [PMID: 31582965 DOI: 10.1155/2019/1247276] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Fontana IC, Souza DG, Souza DO, Gee A, Zimmer ER, Bongarzone S. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases. J Med Chem 2023;66:2330-46. [PMID: 36787643 DOI: 10.1021/acs.jmedchem.2c01572] [Reference Citation Analysis]
2 Kim S, Pajarillo E, Nyarko-Danquah I, Aschner M, Lee E. Role of Astrocytes in Parkinson's Disease Associated with Genetic Mutations and Neurotoxicants. Cells 2023;12. [PMID: 36831289 DOI: 10.3390/cells12040622] [Reference Citation Analysis]
3 Liu F, Qu L, Li H, He J, Wang L, Fang Y, Yan X, Yang Q, Peng B, Wu W, Jin L, Sun D. Advances in Biomedical Functions of Natural Whitening Substances in the Treatment of Skin Pigmentation Diseases. Pharmaceutics 2022;14:2308. [DOI: 10.3390/pharmaceutics14112308] [Reference Citation Analysis]
4 Lei T, Xiao Z, Zhang X, Cai S, Bi W, Yang Y, Wang D, Li Q, Du H. Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats. Cytotherapy 2022:S1465-3249(22)00705-8. [PMID: 35973920 DOI: 10.1016/j.jcyt.2022.06.007] [Reference Citation Analysis]
5 Vastrad B, Vastrad C. Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson’s disease.. [DOI: 10.1101/2022.02.27.482208] [Reference Citation Analysis]
6 Kurkinen M. Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia. Glutamate and Neuropsychiatric Disorders 2022. [DOI: 10.1007/978-3-030-87480-3_7] [Reference Citation Analysis]
7 Karabicici M, Azbazdar Y, Iscan E, Ozhan G. Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases. Membranes (Basel) 2021;11:844. [PMID: 34832073 DOI: 10.3390/membranes11110844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kaur J, Mazzone GL, Aquino JB, Nistri A. Nicotine Neurotoxicity Involves Low Wnt1 Signaling in Spinal Locomotor Networks of the Postnatal Rodent Spinal Cord. Int J Mol Sci 2021;22:9572. [PMID: 34502498 DOI: 10.3390/ijms22179572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Unterman I, Bloch I, Cazacu S, Kazimirsky G, Ben-Zeev B, Berman BP, Brodie C, Tabach Y. Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome. Elife 2021;10:e67085. [PMID: 34355696 DOI: 10.7554/eLife.67085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang Y, Su Y, Yu G, Wang X, Chen X, Yu B, Cheng Y, Li R, Sáez JC, Yi C, Xiao L, Niu J. Reduced Oligodendrocyte Precursor Cell Impairs Astrocytic Development in Early Life Stress. Adv Sci (Weinh) 2021;8:e2101181. [PMID: 34155833 DOI: 10.1002/advs.202101181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li X, Wang W, Yan J, Zeng F. Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease. Front Neurosci 2021;15:678154. [PMID: 34220434 DOI: 10.3389/fnins.2021.678154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Jiang X, Guan Y, Zhao Z, Meng F, Wang X, Gao X, Liu J, Chen Y, Zhou F, Zhou S, Wang X. Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis. Cells 2021;10:839. [PMID: 33917816 DOI: 10.3390/cells10040839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
13 Unterman I, Bloch I, Cazacu S, Kazimirsky G, Berman BP, Ben-zeev B, Brodie C, Tabach Y. Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome.. [DOI: 10.1101/2021.02.14.431162] [Reference Citation Analysis]
14 Angelopoulou E, Paudel YN, Julian T, Shaikh MF, Piperi C. Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target? Mol Neurobiol 2021;58:1372-91. [PMID: 33175322 DOI: 10.1007/s12035-020-02201-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]